Is a Short Squeeze on the Cards for WELL Health Stock?

Here’s why WELL Health stock is all set to add to its 14% gain this week.

| More on:

Short-sellers have had a tough time in recent days. Retail traders have initiated multiple short squeezes on stocks such as AMC Entertainment, BlackBerry, GameStop, Sundial Growers, and Clover Health. In fact, Clover Health stock was up 85% yesterday and has surged over 20% in pre-market trading today. Clover Health’s trading volume was around 723 million shares on June 8, and it’s quite evident that the Reddit army has taken charge, sending the stock to record highs. 

Another stock that is on the radar of retail traders is Canadian company WELL Health Technologies (TSX:WELL). While WELL stock has a high short-interest ratio, it is also fundamentally strong compared to the other stocks discussed above, making it a better bet right now. 

Why is WELL Health stock a solid long-term bet?

WELL Health continues to grow rapidly via accretive acquisitions. It just completed a $206 million acquisition of “MyHealth,” making it the largest private clinic operator in Canada. This is one of many major acquisitions the company has closed in 2021. Earlier this year, it announced a $372.9 million acquisition of CRH Medical, which significantly increased the company’s footprint south of the border.

The CRH Medical acquisitions led to JP Morgan extending an existing credit line by US$100 million, while Royal Bank of Canada provided another $200 million via a secured credit facility to close the MyHealth buyout.

This all comes on the back of a recent $305 million financing that was priced at a 25% premium to WELL Health’s stock price. The investment round was led by the 29th richest man in the world, Sir Li Ka-Shing. Since then, the company has been on an acquisition spree, positioning itself as a true multi-channel digital healthcare leader.

These developments have garnered attention from major institutions like JP Morgan and RBC as well as from renowned law firm Fenwick & West, which helped companies like Facebook, Amazon, Cisco, and Coinbase with their IPOs. 

WELL Health has officially engaged Fenwick & West to assist them with an IPO to list on the NASDAQ in Q4 of 2021. Investors should note that digital health companies in the U.S. are trading at a far higher multiple compared to WELL Health. In fact, WELL stock is trading at a significant discount and should gain momentum to end the year at a higher price. 

What’s next for WELL Health investors?

While most meme stocks have underperformed the broader markets prior to the short squeezes, WELL Health stock has been on an absolute tear. In fact, the stock is up a staggering 8,000% since its IPO. In the last two trading sessions, shares have surged close to 14%.

Even after its phenomenal performance, WELL Health shares are trading 12% below all-time highs. Its low price-to-sales multiple and rising profit margins make it a top bet for 2021 and beyond. While most meme stocks will take a breather once normalcy returns, WELL Health should continue to move higher and generate outsized returns to investors.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. JPMorgan Chase is an advertising partner of The Ascent, a Motley Fool company. Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to its CEO, Mark Zuckerberg, is a member of The Motley Fool's board of directors. The Motley Fool owns shares of and recommends Amazon and Facebook. The Motley Fool recommends BlackBerry and recommends the following options: long January 2022 $1,920 calls on Amazon and short January 2022 $1,940 calls on Amazon. Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Tech Stocks

person on phone leaning against outside wall with scenic view at airbnb rental property
Tech Stocks

3 Canadian Growth Stocks to Buy for Long-Term Returns

These three growth stocks may be down now, but don't count them out, especially for long-term growth.

Read more »

An investor uses a tablet
Tech Stocks

If I Could Only Buy 2 Stocks in 2025, These Would Be My Top Picks

Are you looking for stocks you can buy in 2025 and be confident of good returns? Consider buying these two…

Read more »

Canadian Dollars bills
Dividend Stocks

2 Incredibly Cheap Canadian Growth Stocks to Buy Before It’s Too Late

Buying cheap stocks needs patience and a long-term investment approach. Only then can they give you extraordinary returns.

Read more »

dividend growth for passive income
Tech Stocks

2 Canadian Growth Stocks Set to Skyrocket in the Next 12 Months

There are some great growth stocks out there for investors to consider, but of them all these two look like…

Read more »

A small flower grows out of a concrete crack.
Tech Stocks

Got $3,000? 2 Monster Growth Stocks to Buy Right Now Without Hesitation 

Here is a method to identify monster growth stocks in which you can invest $3,000 and let your money grow…

Read more »

hand stacks coins
Tech Stocks

2 Stocks That Could Turn $100,000 Into $1 Million

When it comes to winning growth stocks, these two have made millionaires time and again.

Read more »

AI microchip
Tech Stocks

2 Canadian AI Stocks Poised for Significant Gains

If you are looking to ride a decisive bull market phase from the beginning, discounted AI stocks in Canada might…

Read more »

Woman in private jet airplane
Tech Stocks

Could This Undervalued Canadian Stock Be a Millionaire-Maker? 

Futuristic growth stocks can be your ticket to millionaire status.

Read more »